Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Portfolio Pulse from Charles Gross
Advanced Health Intelligence Ltd (NASDAQ:AHI) announced it will launch a mobile phone-based Atrial Fibrillation (AF) assessment service in Q2 2024. The service is part of an expansion of the company's Biometric Health Assessment suite, following a binding agreement with Qompium NV. The AF-Scan application is medically approved in multiple regions, including the USA, and aims to address the global prevalence of AF, which affects approximately 60 million people and significantly increases the risk of stroke.
November 30, 2023 | 10:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Advanced Health Intelligence Ltd is set to expand its product offering with a mobile AF assessment service, which has medical approval in several major markets. This could potentially open up new revenue streams and market opportunities.
The announcement of a new product launch, especially in the healthcare technology sector, is typically received positively by the market as it indicates potential growth and expansion. Given the medical approval in multiple regions and the high prevalence of AF, this service could significantly impact AHI's market position and revenue. However, the impact score is not at the maximum due to the launch being planned for Q2 2024, which is still some time away, and the market's reaction may be tempered by the wait and execution risks.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100